secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED GUARDIAN INC (UG)
CIK:        0000101295
Form:       8-K
Filed at:   2025-03-21T23:59:59+00:00
Accession:  0001171843-25-001610
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United-Guardian FY 2024 net sales +12% to $12.18M; EPS $0.71 vs $0.56
---------------------------------------------------------------------

- Net income $3.25M ($0.71 per share) vs $2.58M ($0.56) in FY 2023.
- Cosmetics ingredients sales surged 32%; medical lubricants up 16%.
- Pharmaceutical sales fell 5% due to Renacidin supply disruption into Q1 2024.
- Management expects Renacidin sales to recover to prior levels in 2025.
- Growth driven by increased demand from largest distributor and Chinese accounts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/101295/000117184325001610/0001171843-25-001610-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/101295/000117184325001610/f8k_032025.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-001610

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer